An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer

BMC Genomics
|December 19, 2015
PubMed
Abstract

Insights

Researchers identified key protein kinase targets in triple-negative breast cancer (TNBC) using a novel bioinformatics approach. This study predicts potential drug compounds to treat this aggressive cancer, offering new therapeutic avenues.

Area of Science:

  • Oncology
  • Bioinformatics
  • Pharmacology

Background:

  • Triple-Negative Breast Cancer (TNBC) is an aggressive subtype with limited therapeutic options beyond chemotherapy.
  • Identifying specific molecular targets is crucial for developing effective TNBC treatments.

Purpose of the Study:

  • To determine kinase dependency in TNBC cell lines.
  • To predict potential inhibitory compounds for identified kinases using bioinformatics.

Main Methods:

  • Integrated gene expression, pharmacological profiling, and kinase binding data.
  • Employed a novel bioinformatics approach, Kinase Addiction Ranker (KAR).
  • Queried K-Map to identify compounds targeting predicted kinases.

Main Results:

  • Dissected kinase dependency across 12 TNBC cell lines.
  • Identified candidate kinases as potential therapeutic targets.
  • Validated predictions using existing and new experimental data.

Conclusions:

  • An integrative bioinformatics analysis successfully determined kinase dependency in TNBC.
  • Revealed candidate kinases for further investigation in TNBC treatment strategies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K